Catalyst Pharmaceuticals Story

Macroaxis does not monitor all media channels or aggregates social signals for Catalyst Pharmaceuticals. But even though we do not provide professional-grade financial sentiment analysis on Catalyst Pharmaceuticals, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Catalyst Pharmaceuticals. Check also Catalyst Pharmaceuticals Hype Analysis, Catalyst Pharmaceuticals Correlation and Catalyst Pharmaceuticals Performance
Catalyst Pharmaceuticals, Inc. A Detailed Look at its Institutional ...
Catalyst Pharmaceuticals, Inc. reached 201.96 versus a 1year low price of 0.51. The stock was last seen 1.99 higher, reaching at 1.54 on Mar. 17, 2017. Stock Value Analysis Catalyst Pharmaceuticals, Inc. The Oracle Examiner The Catalyst Pharmaceuticals Inc Posts Quarterly Earnings Results ... Petro Global News 24

Read More...   

Story Momentum

This media report from postanalyst.com distributed on March 20, 2017 was a factor to the next trading day price appreciation.The overall trading delta against the next closing price was 2.41% . The overall trading delta when the story was published against the current closing price is 31.93% .

Similar stores for Catalyst Pharmaceuticals

six days ago at http://www.nasdaq.com 
Catalyst Pharmaceuticals Focuses on Development of Firdapse
nasdaq News
Being a development-stage company, Catalyst Pharmaceuticals does not have any approved product in its portfolio yet. Catalyst Pharmaceuticals Inc Upgraded to quotBuyquot by Zacks Investment Research - Markets Daily Catalyst Pharmaceuticals Receiving Favorable Media Coverage, Analysis Shows - Transcript Daily
over three weeks ago at http://morganleader.com 
Streetwise Investors Taking Note of Catalyst Pharmaceuticals, Inc.
news
Shares of Catalyst Pharmaceuticals, Inc. are on our watchlist today as the stock has moved -0.54 from the open, touching 1.84 on a recent trade.
over a month ago at http://bentonbulletin.com 
Trading Watch Indicators in Review for Catalyst Pharmaceuticals Inc
news
Let take a closer look at some technical levels for Catalyst Pharmaceuticals Inc . The 14-day RSI is presently at 59.41, the 7-day is 50.33, and the 3-day is spotted at 41.49.

Did you try this?

Run Volatility Analysis Now
   

Volatility Analysis

Get historical volatility and risk analysis based on latest market data
Hide  View All  Next  Launch Volatility Analysis

Operating Margin

Operating Margin Comparative Analysis
  Operating Margin 
      Catalyst Pharmaceuticals Comparables 
Catalyst Pharmaceuticals is currently under evaluation in operating margin category among related companies. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.